Figure 7. (A) Effects of syr+cos on inflammatory pathway, cell cycle and apoptosis-related proteins respectively. (B) Effects of syr+cos on NF-κB related signaling pathway. (C) Effects of syr+cos on p65 (nucleus) and p65 (cytosol). Note: The data represent the mean ± SD (n = 5) per group. **P < 0.01 vs control group; ##P < 0.01 vs LPS treatment group.